Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gritsch

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Trends in Molecular Medicine|October 18, 2024
Molecular evolution of central nervous system metastasis and therapeutic implicationsDavid Gritsch, Priscilla K Brastianos
Frontiers in Neurology|October 17, 2022
Drug-related immune-mediated myelopathiesDavid Gritsch, Cristina Valencia-Sanchez
Journal of Neuro-Oncology|March 21, 2022
Relevant pharmacologic interactions in the concurrent management of brain tumor-related epilepsy and venous thromboembolism: a systematic reviewDavid Gritsch, L Nicolas Gonzalez Castro
Current Treatment Options in Oncology|February 1, 2024
Integrating Systemic Therapies into the Multimodality Therapy of Patients with CraniopharyngiomaDavid Gritsch, Sandro Santagata, Priscilla K Brastianos
The Neurologist|May 20, 2022
Hirayama Disease: A 15-Year-Old Male With Progressive Distal Right Upper Extremity WeaknessDavid Gritsch, Amir A Mbonde, Julie Khoury
Journal of Experimental Therapeutics & Oncology|February 1, 2011
Tamoxifen enhances the anti-proliferative effect of roscovitine, a selective cyclin-dependent kinase inhibitor, on human ER-positive human breast cancer cellsDavid Gritsch, Margarita Maurer, Nora Zulehner, et al.
Neuro-Oncology Practice|October 13, 2025
Nutritional strategies in the management of diffuse gliomas: A systematic reviewDavid Gritsch, Clara Baselga-Garriga, L Nicolas Gonzalez Castro
Journal of Cellular Biochemistry|February 11, 2011
Interference with ER-α enhances the therapeutic efficacy of the selective CDK inhibitor roscovitine towards ER-positive breast cancer cellsJózefa Węsierska-Gądek, David Gritsch, Nora Zulehner, et al.
Journal of Cellular Biochemistry|February 18, 2011
Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cellsJózefa Węsierska-Gądek, David Gritsch, Nora Zulehner, et al.
Journal of Neuroimmunology|November 4, 2022
Aquaporin-4 IgG neuromyelitis optica spectrum disorder onset after Covid-19 vaccination: Systematic reviewEhab Harahsheh, Marcus Callister, Shemonti Hasan, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Trends in Molecular Medicine|October 18, 2024
Molecular evolution of central nervous system metastasis and therapeutic implicationsDavid Gritsch, Priscilla K Brastianos
Frontiers in Neurology|October 17, 2022
Drug-related immune-mediated myelopathiesDavid Gritsch, Cristina Valencia-Sanchez
Journal of Neuro-Oncology|March 21, 2022
Relevant pharmacologic interactions in the concurrent management of brain tumor-related epilepsy and venous thromboembolism: a systematic reviewDavid Gritsch, L Nicolas Gonzalez Castro
Current Treatment Options in Oncology|February 1, 2024
Integrating Systemic Therapies into the Multimodality Therapy of Patients with CraniopharyngiomaDavid Gritsch, Sandro Santagata, Priscilla K Brastianos
The Neurologist|May 20, 2022
Hirayama Disease: A 15-Year-Old Male With Progressive Distal Right Upper Extremity WeaknessDavid Gritsch, Amir A Mbonde, Julie Khoury
Journal of Experimental Therapeutics & Oncology|February 1, 2011
Tamoxifen enhances the anti-proliferative effect of roscovitine, a selective cyclin-dependent kinase inhibitor, on human ER-positive human breast cancer cellsDavid Gritsch, Margarita Maurer, Nora Zulehner, et al.
Neuro-Oncology Practice|October 13, 2025
Nutritional strategies in the management of diffuse gliomas: A systematic reviewDavid Gritsch, Clara Baselga-Garriga, L Nicolas Gonzalez Castro
Journal of Cellular Biochemistry|February 11, 2011
Interference with ER-α enhances the therapeutic efficacy of the selective CDK inhibitor roscovitine towards ER-positive breast cancer cellsJózefa Węsierska-Gądek, David Gritsch, Nora Zulehner, et al.
Journal of Cellular Biochemistry|February 18, 2011
Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cellsJózefa Węsierska-Gądek, David Gritsch, Nora Zulehner, et al.
Journal of Neuroimmunology|November 4, 2022
Aquaporin-4 IgG neuromyelitis optica spectrum disorder onset after Covid-19 vaccination: Systematic reviewEhab Harahsheh, Marcus Callister, Shemonti Hasan, et al.
Pageof 4